These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13775313)

  • 21. [Inhibitory action of sulfonylureas on the arginase activity of guinea pig liver homogenates].
    TROPEANO L; DI STEFANO S; BELFIORE F
    Boll Soc Ital Biol Sper; 1960 May; 36():495-8. PubMed ID: 13839478
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of the sulphonylureas on fibrinolysis.
    FEARNLEY GR; CHAKRABARTI R; VINCENT CT
    Lancet; 1960 Sep; 2(7151):622-5. PubMed ID: 13698486
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the action of hypoglycemia-producing biguanide and sulfonylurea compounds on oxidative phosphorylation.
    FALCONE AB; MAO RL; SHRAGO E
    J Biol Chem; 1962 Mar; 237():904-9. PubMed ID: 13891416
    [No Abstract]   [Full Text] [Related]  

  • 24. On the hypoglycemizing effect of metahexamide.
    GARATTINI S; JORI A; PALMA V; TESSARI L
    Experientia; 1959 Oct; 15():384-5. PubMed ID: 13826354
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on the significant role of the liver in sulfonylurea hypoglycemia.
    FRAWLEY TF; SHELLEY TF; RUNYAN JW; MARGULIES EJ; CINCOTTI JJ
    Ann N Y Acad Sci; 1959 Sep; 82():460-78. PubMed ID: 13824663
    [No Abstract]   [Full Text] [Related]  

  • 26. The current status of sulphonylureas in experimental and clinical diabetes.
    TYLER DB
    J Indian Med Assoc; 1960 Dec; 35():549-51. PubMed ID: 13778866
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus].
    GUTSCHE H
    Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204
    [No Abstract]   [Full Text] [Related]  

  • 28. [Exclusion of the sulfonylureas from any evident inhibitory action on the aldolase activity of guinea pig liver homogenates].
    TROPEANO L; DI STEFANO S; BELFIORE F
    Boll Soc Ital Biol Sper; 1960 May; 36():498-501. PubMed ID: 13839477
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.
    Jackson JE; Bressler R
    Drugs; 1981 Oct; 22(4):295-320. PubMed ID: 7030708
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Hansen JM; Christensen LK
    Drugs; 1977 Jan; 13(1):24-34. PubMed ID: 401727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
    Augusti KT; Kurup PA
    Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
    [No Abstract]   [Full Text] [Related]  

  • 33. [Selective destruction of the alpha cells of the islets of the pancreas in rabbits by administration of chloride of cobalt. Its relation to the mechanism of action of sulfonylureas].
    VAISSMAN I; da SILVA I; PEDERSOLI WM
    Med Cir Farm; 1959 Sep; 281():402-14. PubMed ID: 13840726
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibitory action of sulfonylureas on the succinic dehydrogenase activity of guinea pig heart homogenates].
    TROPEANO L; BELFIORE F; DI STEFANO S
    Boll Soc Ital Biol Sper; 1960 May; 36():491-5. PubMed ID: 13839472
    [No Abstract]   [Full Text] [Related]  

  • 35. [ON THE CLINICAL ADJUSTABILITY OF VARIOUS FORMS OF DIABETES IN DELAYED-ACTION INSULIN THERAPY, COMBINED AND EXCLUSIVELY ORAL THERAPY WITH SULFONYLUREA DERIVATIVES AND BIGUANIDES].
    KNICK B; FOLKERT F
    Munch Med Wochenschr; 1965 Jan; 107():83-8. PubMed ID: 14301179
    [No Abstract]   [Full Text] [Related]  

  • 36. [The influence of insulin and oral antidiabetics on the glucose uptake and gas exchange of isolated fatty tissue].
    HUMBEL R; STAUB M; FROESCH ER
    Schweiz Med Wochenschr; 1959 Apr; 89():381-2. PubMed ID: 14403977
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals.
    CERLETTI P; GREGOLIN C
    Clin Chim Acta; 1959 Jul; 4():579-82. PubMed ID: 13808852
    [No Abstract]   [Full Text] [Related]  

  • 38. Assay of liver membrane insulin receptors in obese, hyperglycaemic (ob/ob) mice: stimulant effect of an oral antidiabetic sulphonylurea drug [proceedings].
    Greenstein BD
    Br J Pharmacol; 1979 May; 66(1):86P. PubMed ID: 454969
    [No Abstract]   [Full Text] [Related]  

  • 39. Maternal-fetal transport of hypoglycaemic drugs.
    Garcia-Bournissen F; Feig DS; Koren G
    Clin Pharmacokinet; 2003; 42(4):303-13. PubMed ID: 12648023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term use of antidiabetic sulfonylureas on thyroid weight and arteriosclerosis.
    NIKKILA EA; TEIR H
    Ann Med Exp Biol Fenn; 1960; 38():182-5. PubMed ID: 14427203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.